Technology | Artificial Intelligence | November 09, 2018

ContextVision Introduces AI-Powered Image Enhancement for Digital Radiography

Altumira software addresses challenges regarding durability and high image quality for all X-ray and angiography exams

ContextVision Introduces AI-Powered Image Enhancement for Digital Radiography

November 9, 2018 — With the integration of deep learning technology, ContextVision takes digital radiography (DR) to new levels with its latest image enhancement platform, Altumira.

ContextVision’s new technology supports clinicians to accurately interpret medical imaging, leading the way to better diagnoses and improved patient care. Altumira is specially designed to meet the demanding needs of DR, and addresses significant challenges regarding durability and high image quality that have been difficult to solve before, including:

  • Varying exposure conditions between patients;
  • A wide variety of image characteristics and requirements for all types of anatomies; and
  • Varying dose and intensity levels, as well as organs and collimators in motion in dynamic sequences.

Altumira is designed for all DR systems, from plain X-ray to the most advanced angiography systems. The software can provide greater contrast and resolution in parallel with intelligent noise suppression and harmonized intensity levels also for low-dose fluoroscopy as well as in high-quality angiography sequences.

This new product adds to ContextVision’s present product portfolio of image enhancement for 2-D/3-D/4-D ultrasound, magnetic resonance imaging (MRI), X-ray and mammography.

Demonstrations of Altumira, as well as ContextVision’s other solutions, will occur during the 2018 Radiological Society of North America (RSNA) annual meeting, Nov. 25-30 in Chicago.

For more information: www.contextvision.com

Related Content

Imaging center leaders and radiologists identify benefits, challenges and areas of use associated with artificial intelligence usage in healthcare

Image by Gerd Altmann from Pixabay 

News | Artificial Intelligence | January 28, 2020
January 28, 2020 — Definitive Healthcare, a provider of da
Pulmonary imaging is important in the diagnosis of the acute lung injury associated with vaping, known as electronic cigarette or vaping product use-associated lung injury (EVALI)

Image by Sarah J. from Pixabay

News | Lung Cancer | January 28, 2020
January 28, 2020 — Pulmonary imaging is important in the diagnosis of the acute lung injury associated with...

Image by Adam Radosavljevic from Pixabay 

News | Radiology Business | January 27, 2020
January 27, 2020 —  Hg, a specialist private equity investor focused on software and service businesses, announced th
Rayence C-Series wireless DR detector

Image courtesy of Rayence

News | Digital Radiography (DR) | January 27, 2020
January 27, 2020 — The expansion of med...
Sponsored Content | Videos | Mammography | January 24, 2020
Imaging Technology News Contributing Editor Greg Freiherr interviewed...
he U.S. Food and Drug Administration (FDA) has issued a final order to reclassify medical image analyzers applied to mammography breast cancer, ultrasound breast lesions, radiograph lung nodules and radiograph dental caries detection, postamendments class III devices (regulated under product code MYN), into class II (special controls), subject to premarket notification

Image courtesy of iCAD

News | Computer-Aided Detection Software | January 22, 2020
January 22, 2020 — The U.S.
Medical imaging technology company Oxipit announced partnership with Swiss medical distribution company Healthcare Konnect to bring ChestEye AI imaging suite to healthcare institutions in Nigeria
News | Artificial Intelligence | January 22, 2020
January 22, 2020 — Medical imaging technology company Oxipit ann
Hitachi Healthcare Americas announced that it will create a new dedicated research and development facility within its North American headquarters facility in Twinsburg, Ohio
News | Radiology Business | January 21, 2020
January 21, 2020 — Hitachi Healthcare Americas announced that it will create a new dedicated research and development